Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML

2012 
Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    15
    References
    25
    Citations
    NaN
    KQI
    []